Sep-2024
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
Trilogy 710 has seen a fluctuating performance in the California market, particularly within the concentrates category. Notably, the brand was absent from the top 30 rankings in both June and August 2024, indicating a struggle to maintain a steady market presence during those months. However, a significant improvement was observed in September 2024, where Trilogy 710 climbed to the 26th position, reflecting a positive trend and a potential rebound in consumer interest or strategic adjustments. This upward movement suggests that Trilogy 710 may have implemented successful changes in product offerings or marketing strategies, although more detailed analysis would be required to pinpoint the exact drivers of this improvement.
Despite some setbacks in the middle of the year, Trilogy 710's sales trajectory in California shows an interesting pattern. The brand's sales figures increased from June to July 2024, followed by a sharp decline in August, before experiencing a substantial rise in September. This volatility might indicate seasonal demand fluctuations or competitive pressures impacting their market share. The absence from the top 30 in certain months highlights the competitive nature of the concentrates category in California, where maintaining a consistent presence can be challenging. Observing how Trilogy 710 adapts to these market dynamics in the coming months will be crucial for understanding its long-term positioning in the state.
Competitive Landscape
In the competitive landscape of California's concentrates category, Trilogy 710 has experienced significant fluctuations in its market positioning from June to September 2024. Initially ranked at 40th in June, Trilogy 710 saw a slight improvement to 39th in July, only to drop out of the top 20 in August with a rank of 67th, before making a remarkable recovery to 26th in September. This volatility contrasts with competitors like Clsics, which showed a consistent upward trend from 42nd to 28th over the same period. Meanwhile, Everyday Dabs experienced a decline from 11th to 24th, and Halfpipe Cannabis improved from 33rd to 25th. The fluctuations in Trilogy 710's rank suggest a dynamic market presence, with its September rebound indicating potential strategic adjustments or successful marketing efforts. This analysis highlights the importance of understanding market trends and competitor movements for brands aiming to enhance their market share in the competitive California concentrates segment.
Notable Products
In September 2024, the top-performing product from Trilogy 710 was Strawberry Fuego Live Rosin (1g) in the Concentrates category, maintaining its number one rank from August with sales reaching 667 units. Tropical Monsoon Live Rosin (1g) climbed from fourth place in August to second place in September, indicating a notable increase in popularity. Government Apples Live Rosin (1g) also improved its standing, moving from fifth to third place over the same period. Black Garlic Live Rosin (1g) and Peach Gak Live Rosin (1g) both entered the top rankings for the first time in September, sharing the fourth position with equal sales figures. This reshuffling of ranks suggests a dynamic shift in consumer preferences within Trilogy 710's product lineup.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.